APA (7th ed.) Citation

T, T., & A, M. (2025). Editorial comment on "Dutasteride, a 5 alpha-reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia". International journal of urology : official journal of the Japanese Urological Association, 32(2), 157. https://doi.org/10.1111/iju.15631

Chicago Style (17th ed.) Citation

T, Tanaka, and Minami A. "Editorial Comment on "Dutasteride, a 5 Alpha-reductase Inhibitor, Could Be Associated with the Exacerbation of Inflammation in Patients with Benign Prostatic Hyperplasia"." International Journal of Urology : Official Journal of the Japanese Urological Association 32, no. 2 (2025): 157. https://doi.org/10.1111/iju.15631.

MLA (9th ed.) Citation

T, Tanaka, and Minami A. "Editorial Comment on "Dutasteride, a 5 Alpha-reductase Inhibitor, Could Be Associated with the Exacerbation of Inflammation in Patients with Benign Prostatic Hyperplasia"." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 32, no. 2, 2025, p. 157, https://doi.org/10.1111/iju.15631.